HRP960268B1 - TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES - Google Patents

TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES

Info

Publication number: HRP960268B1
Authority: HR; Croatia
Prior art keywords: triazolo; pyrazolo; pyridines; tricyclic; dihydro
Prior art date: 1995-06-06

Application number

HR960268A

Other languages

English (en)

Inventor

Allen Jacob Duplantier

Kelvin Cooper

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1996-06-06

Publication date

2002-12-31

1996-06-06 Application filed by Pfizer filed Critical Pfizer

1997-08-31 Publication of HRP960268A2 publication Critical patent/HRP960268A2/hr

2002-12-31 Publication of HRP960268B1 publication Critical patent/HRP960268B1/xx

Links

RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Oncology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HR960268A 1995-06-06 1996-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES HRP960268B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CA002223624A CA2223624C (fr)	1995-06-06	1995-06-06	5,6-dihydro-9h-pyrazolo[3,4-c]-1,2-4-triazolo[4,3-.alpha.]pyridines tricycliques
PCT/IB1995/000429 WO1996039408A1 (fr)	1995-06-06	1995-06-06	5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2-4-TRIAZOLO[4,3-α]PYRIDINES TRICYCLIQUES
HU9601541A HUP9601541A3 (en)	1995-06-06	1996-06-05	Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (2)

Publication Number	Publication Date
HRP960268A2 HRP960268A2 (en)	1997-08-31
HRP960268B1 true HRP960268B1 (en)	2002-12-31

Family

ID=89994031

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR960268A HRP960268B1 (en)	1995-06-06	1996-06-06	TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES

Country Status (43)

Country	Link
US (1)	US6004974A (fr)
EP (1)	EP0837860B1 (fr)
JP (1)	JP3107827B2 (fr)
KR (2)	KR100191972B1 (fr)
CN (1)	CN1061044C (fr)
AP (1)	AP609A (fr)
AR (1)	AR002745A1 (fr)
AT (1)	ATE214700T1 (fr)
AU (1)	AU694871B2 (fr)
BG (1)	BG62568B1 (fr)
BR (1)	BR9602627A (fr)
CA (1)	CA2223624C (fr)
CO (1)	CO4700460A1 (fr)
CZ (1)	CZ287251B6 (fr)
DE (1)	DE69525978T2 (fr)
DK (1)	DK0837860T3 (fr)
DZ (1)	DZ2044A1 (fr)
ES (1)	ES2172583T3 (fr)
FI (1)	FI114097B (fr)
HR (1)	HRP960268B1 (fr)
HU (1)	HUP9601541A3 (fr)
IL (1)	IL118485A (fr)
IS (1)	IS1913B (fr)
LV (1)	LV11620B (fr)
MA (1)	MA23893A1 (fr)
MX (1)	MX9709897A (fr)
MY (1)	MY116527A (fr)
NO (1)	NO306256B1 (fr)
NZ (1)	NZ286734A (fr)
OA (1)	OA10458A (fr)
PL (1)	PL184195B1 (fr)
PT (1)	PT837860E (fr)
RO (1)	RO115881B1 (fr)
RU (1)	RU2161158C2 (fr)
SA (1)	SA96170065B1 (fr)
SG (1)	SG54341A1 (fr)
SI (1)	SI9600186A (fr)
SK (1)	SK282167B6 (fr)
TN (1)	TNSN96083A1 (fr)
TR (1)	TR199600482A1 (fr)
TW (1)	TW460469B (fr)
WO (1)	WO1996039408A1 (fr)
YU (1)	YU49346B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2792938B1 (fr)	1999-04-28	2001-07-06	Warner Lambert Co	NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
EP1380585B1 (fr) *	1999-04-30	2004-11-10	Pfizer Products Inc.	Pyrazolopyridinone comme intermédiaire
US6326495B2 (en)	1999-04-30	2001-12-04	Pfizer Inc.	Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1212089B1 (fr)	1999-08-21	2006-03-22	ALTANA Pharma AG	Combinaison synergetique de roflumilast et salmeterol
CA2402384A1 (fr) *	2000-03-16	2001-09-20	Inflazyme Pharmaceuticals Ltd.	Inhibiteurs benzyles de pde4
BR0209992A (pt) *	2001-05-25	2004-04-06	Pfizer	Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
WO2002096423A2 (fr) *	2001-05-25	2002-12-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Combinaison d'un inhibiteur de pde4 et de tiotropium ou d'un derive de ce dernier destinee au traitement des maladies obstructives des voies aeriennes et d'autres maladies inflammatoires
GB0122031D0 (en) *	2001-09-12	2001-10-31	Pfizer Ltd	Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) *	2001-12-07	2002-01-30	Pfizer Ltd	Pharmaceutical combination
US20050107420A1 (en) *	2002-05-23	2005-05-19	Boehringe Ingelheim Pharma Gmbh & Co. Kg	Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
MXPA05010373A (es)	2003-04-01	2005-12-05	Applied Research Systems	Inhibidores de fosfodiesterasas en infertilidad.
WO2006075748A1 (fr) *	2005-01-17	2006-07-20	Santen Pharmaceutical Co., Ltd.	Agent therapeutique pour maladie conjonctivale allergique
US8008317B2 (en) *	2005-06-10	2011-08-30	Merck Sharp & Dohme Corp.	Inhibitors of akt activtiy
RU2008119323A (ru)	2005-10-19	2009-11-27	Рэнбакси Лабораториз Лимитед (In)	Фармацевтические композиции мускаринового рецептора
EP2359826B1 (fr)	2006-07-05	2013-10-30	Takeda GmbH	Combinaison d'un inhibiteur de la HMG-CoA reductase rosuvastatine avec un inhibiteur de la phosphodiesterase 4, tel que roflumilast, roflumilast-N-oxyde, pour le traitement de maladies pulmonaires inflammatoires
JP5579724B2 (ja) *	2008-10-17	2014-08-27	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ホスファチジルイノシトール−３−キナーゼ（ｐｉ−３キナーゼ）阻害剤としてのテトラ−アザ−複素環
ES2527363T3 (es) *	2009-12-04	2015-01-22	Nerviano Medical Sciences S.R.L.	Derivados de triciclopirazol
WO2013084182A1 (fr)	2011-12-08	2013-06-13	Glenmark Pharmaceuticals S.A.	Composition pharmaceutique comprenant un inhibiteur de l'enzyme pde4 et un agent analgésique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3697532A (en) *	1970-08-12	1972-10-10	Squibb & Sons Inc	5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
SU1048746A1 (ru) *	1982-01-29	1987-12-30	Институт физико-органической химии и углехимии АН УССР	Гидробромид 8-адамантил-1,з-диметилимидазо 4,5-с имидазо 1,2-а пиридин-2-она,обладающий спазмолитическим действием
FR2579208B1 (fr) *	1985-03-22	1987-05-07	Sanofi Sa	Nouveaux derives de le 5-h pyrido (3', 4' : 4,5) pyrrolo (3,2-c) pyridine, leur procede de preparation et leur activite antitumorale
US4940715A (en) *	1988-05-17	1990-07-10	Kissei Pharmaceutical Co., Ltd.	5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
CA2030056C (fr) *	1989-11-17	1995-10-17	Karl D. Hargrave	5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines et leur utilisation pour la prevention ou le traitement de l'infection par le hiv
RU2131876C1 (ru) *	1993-07-06	1999-06-20	Пфайзер Инк.	Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения
CA2143143A1 (fr) *	1994-03-08	1995-09-09	Toshihiko Tanaka	Derives de la 3-phenylpyrrolidine

1995
- 1995-06-06 JP JP08511176A patent/JP3107827B2/ja not_active Expired - Fee Related
- 1995-06-06 DE DE69525978T patent/DE69525978T2/de not_active Expired - Fee Related
- 1995-06-06 MX MX9709897A patent/MX9709897A/es unknown
- 1995-06-06 DK DK95918707T patent/DK0837860T3/da active
- 1995-06-06 EP EP95918707A patent/EP0837860B1/fr not_active Expired - Lifetime
- 1995-06-06 PT PT95918707T patent/PT837860E/pt unknown
- 1995-06-06 US US08/973,590 patent/US6004974A/en not_active Expired - Fee Related
- 1995-06-06 SK SK718-96A patent/SK282167B6/sk unknown
- 1995-06-06 WO PCT/IB1995/000429 patent/WO1996039408A1/fr not_active Ceased
- 1995-06-06 AT AT95918707T patent/ATE214700T1/de not_active IP Right Cessation
- 1995-06-06 CA CA002223624A patent/CA2223624C/fr not_active Expired - Fee Related
- 1995-06-06 ES ES95918707T patent/ES2172583T3/es not_active Expired - Lifetime
1996
- 1996-05-02 TW TW085105271A patent/TW460469B/zh not_active IP Right Cessation
- 1996-05-06 AP APAP/P/1996/000806A patent/AP609A/en active
- 1996-05-20 AR ARP960102626A patent/AR002745A1/es unknown
- 1996-05-27 PL PL96314459A patent/PL184195B1/pl not_active IP Right Cessation
- 1996-05-30 IL IL11848596A patent/IL118485A/xx not_active IP Right Cessation
- 1996-06-03 IS IS4350A patent/IS1913B/is unknown
- 1996-06-04 SA SA96170065A patent/SA96170065B1/ar unknown
- 1996-06-04 LV LVP-96-174A patent/LV11620B/en unknown
- 1996-06-04 BR BR9602627A patent/BR9602627A/pt active Search and Examination
- 1996-06-05 CZ CZ19961626A patent/CZ287251B6/cs not_active IP Right Cessation
- 1996-06-05 SG SG1996009983A patent/SG54341A1/en unknown
- 1996-06-05 NO NO962320A patent/NO306256B1/no unknown
- 1996-06-05 YU YU34696A patent/YU49346B/sh unknown
- 1996-06-05 DZ DZ960088A patent/DZ2044A1/fr active
- 1996-06-05 HU HU9601541A patent/HUP9601541A3/hu unknown
- 1996-06-05 BG BG100640A patent/BG62568B1/bg unknown
- 1996-06-05 MY MYPI96002201A patent/MY116527A/en unknown
- 1996-06-05 AU AU54773/96A patent/AU694871B2/en not_active Ceased
- 1996-06-05 NZ NZ286734A patent/NZ286734A/en unknown
- 1996-06-05 KR KR1019960020169A patent/KR100191972B1/ko not_active Expired - Fee Related
- 1996-06-05 TN TNTNSN96083A patent/TNSN96083A1/fr unknown
- 1996-06-05 MA MA24263A patent/MA23893A1/fr unknown
- 1996-06-05 RU RU96111027/04A patent/RU2161158C2/ru not_active IP Right Cessation
- 1996-06-06 OA OA60834A patent/OA10458A/en unknown
- 1996-06-06 TR TR96/00482A patent/TR199600482A1/xx unknown
- 1996-06-06 CO CO96029521A patent/CO4700460A1/es unknown
- 1996-06-06 RO RO96-01157A patent/RO115881B1/ro unknown
- 1996-06-06 SI SI9600186A patent/SI9600186A/sl not_active IP Right Cessation
- 1996-06-06 CN CN96107630A patent/CN1061044C/zh not_active Expired - Fee Related
- 1996-06-06 HR HR960268A patent/HRP960268B1/xx not_active IP Right Cessation
1997
- 1997-12-05 FI FI974434A patent/FI114097B/fi active
1998
- 1998-10-24 KR KR1019980044720A patent/KR100225719B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1996039408A1 (fr)	1996-12-12
CZ287251B6 (en)	2000-10-11
CA2223624A1 (fr)	1996-12-12
SG54341A1 (en)	1998-11-16
JP3107827B2 (ja)	2000-11-13
MX9709897A (es)	1998-03-31
SK282167B6 (sk)	2001-11-06
DE69525978D1 (de)	2002-04-25
SK71896A3 (en)	1997-05-07
ES2172583T3 (es)	2002-10-01
IL118485A (en)	2000-02-17
AU5477396A (en)	1996-12-19
SI9600186A (en)	1997-04-30
AU694871B2 (en)	1998-07-30
RO115881B1 (ro)	2000-07-28
MY116527A (en)	2004-02-28
NO306256B1 (no)	1999-10-11
CN1142499A (zh)	1997-02-12
HRP960268A2 (en)	1997-08-31
IL118485A0 (en)	1996-09-12
FI114097B (fi)	2004-08-13
DZ2044A1 (fr)	2002-07-21
BG100640A (bg)	1997-03-31
RU2161158C2 (ru)	2000-12-27
EP0837860B1 (fr)	2002-03-20
IS4350A (is)	1996-12-07
ATE214700T1 (de)	2002-04-15
FI974434L (fi)	1997-12-05
YU34696A (sh)	1999-07-28
PL184195B1 (pl)	2002-09-30
NO962320D0 (no)	1996-06-05
NZ286734A (en)	1998-02-26
IS1913B (is)	2004-02-03
US6004974A (en)	1999-12-21
YU49346B (sh)	2005-07-19
KR970003440A (ko)	1997-01-28
CO4700460A1 (es)	1998-12-29
CZ162696A3 (en)	1997-01-15
AP9600806A0 (en)	1996-07-31
LV11620B (en)	1997-04-20
OA10458A (en)	2002-03-27
JPH10510242A (ja)	1998-10-06
MA23893A1 (fr)	1996-12-31
PT837860E (pt)	2002-07-31
SA96170065B1 (ar)	2005-12-21
PL314459A1 (en)	1996-12-09
FI974434A0 (fi)	1997-12-05
DK0837860T3 (da)	2002-05-27
KR100191972B1 (ko)	1999-06-15
TNSN96083A1 (fr)	2005-03-15
TR199600482A1 (tr)	1997-03-21
AP609A (en)	1997-09-03
EP0837860A1 (fr)	1998-04-29
AR002745A1 (es)	1998-04-29
NO962320L (no)	1996-12-09
KR100225719B1 (en)	1999-10-15
DE69525978T2 (de)	2002-12-19
HU9601541D0 (en)	1996-07-29
LV11620A (lv)	1996-12-20
CA2223624C (fr)	2001-02-20
TW460469B (en)	2001-10-21
BR9602627A (pt)	1998-09-01
BG62568B1 (bg)	2000-02-29
CN1061044C (zh)	2001-01-24
HUP9601541A3 (en)	1997-05-28
HUP9601541A2 (en)	1997-02-28

Legal Events

Date	Code	Title	Description
1996-06-06	AIPI	Request for the grant of a patent on the basis of a substantive examination of a patent application
1997-08-31	A1OB	Publication of a patent application
2002-12-31	B1PR	Patent granted
2007-05-28	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20070528 Year of fee payment: 12
2008-12-07	PBON	Lapse due to non-payment of renewal fee	Effective date: 20080607

Publication	Publication Date	Title
HRP960268B1 (en)	2002-12-31	TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO/3,4-c/-1,2,4-TRIAZOLO/4,3-ALPHA/PYRIDINES
EP0648770A3 (fr)	1995-05-31	Pyrrolo(3,4-c)pyrroles.
IL113912A0 (en)	1995-08-31	Thieno [1,5] benzodiazepine use
ZA942570B (en)	1994-11-11	1,5 benzodiazepine derivatives
HU9403364D0 (en)	1995-02-28	Imidazopyridine
IL116773A0 (en)	1996-05-14	Tricyclic benzazepine compounds and their preparation
ZA949664B (en)	1995-08-15	Imidazopyridines
IL115667A0 (en)	1996-01-19	Bicyclic tetrahydro pyrazolopyridines
HU9401692D0 (en)	1994-09-28	Imidazopyridines
HU9300488D0 (en)	1993-05-28	Tricyclic benzodiazepine derivatives
AP9400657A0 (en)	1994-07-31	1,5 benzodiazepine derivatives
GR3037060T3 (en)	2002-01-31	2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
ZA939291B (en)	1995-06-09	Diazepine derivatives
GB9317692D0 (en)	1993-10-13	Benzodiazepine derivatives
ZA947314B (en)	1995-04-03	Tricyclic derivatives
HU9500007D0 (en)	1995-03-28	Tricyclic cepheme derivatives
ZA94382B (en)	1995-07-19	Tricyclic 1,2,4-triazolo compounds
ZA964649B (en)	1997-12-05	Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines.
ZA948093B (en)	1995-06-05	Tricyclic 1-aminoethylpyrrol -derivatives
GB9308013D0 (en)	1993-06-02	Benzodiazepine derivatives
GB9322270D0 (en)	1993-12-15	Benzodiazepine derivatives
GB9312311D0 (en)	1993-07-28	New benzodiazepine derivatives
HU0200040D0 (en)	2002-03-28	Thiazolo[3,2-a]azepine derivatives and process for their preparation
GB9308926D0 (en)	1993-06-16	Tricyclic compounds
IL135582A0 (en)	2001-05-20	PYRROLO[3,2-b]PYRIDINE PROCESSES AND INTERMEDIATES